SGLT2 Inhibitors and Curcumin Co-loaded Liposomal Formulations as Synergistic Delivery Systems for Heart Failure Therapy

<b>Background/Objectives</b>: As novel synergistic strategy for heart failure (HF), this study explores the formulation and characterization of liposomal systems co-loaded with SGLT2 inhibitors (dapagliflozin—DAPA and empagliflozin—EMPA) and curcumin (Cur). <b>Methods</b>: To enhance liposomal membr...

Deskribapen osoa

Xehetasun bibliografikoak

Egile Nagusiak:	Bianca-Ștefania Profire, Florentina Geanina Lupașcu, Alexandru Sava, Ioana-Andreea Turin-Moleavin, Dana Bejan, Cristian Stătescu, Victorița Șorodoc, Radu-Andy Sascău, Laurențiu Șorodoc, Mariana Pinteala, Lenuța Profire
Formatua:	Artigo
Hizkuntza:	Inglês
Argitaratua:	MDPI AG 2025-07-01
Saila:	Pharmaceutics
Gaiak:	SGLT2 inhibitors curcumin liposomes heart failure
Sarrera elektronikoa:	https://www.mdpi.com/1999-4923/17/8/969
Etiketak:	Etiketa erantsi Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!